Tg Therapeutics (TGTX) Invested Capital: 2016-2025
Historic Invested Capital for Tg Therapeutics (TGTX) over the last 10 years, with Sep 2025 value amounting to $607.2 million.
- Tg Therapeutics' Invested Capital rose 216.00% to $607.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $607.2 million, marking a year-over-year increase of 216.00%. This contributed to the annual value of $222.4 million for FY2024, which is 14.77% down from last year.
- Latest data reveals that Tg Therapeutics reported Invested Capital of $607.2 million as of Q3 2025, which was up 119.66% from $276.4 million recorded in Q2 2025.
- Tg Therapeutics' 5-year Invested Capital high stood at $607.2 million for Q3 2025, and its period low was $27.4 million during Q1 2023.
- Its 3-year average for Invested Capital is $224.1 million, with a median of $222.4 million in 2024.
- In the last 5 years, Tg Therapeutics' Invested Capital skyrocketed by 35,237.62% in 2021 and then plummeted by 83.90% in 2023.
- Over the past 5 years, Tg Therapeutics' Invested Capital (Quarterly) stood at $238.1 million in 2021, then crashed by 75.40% to $58.6 million in 2022, then skyrocketed by 345.33% to $260.9 million in 2023, then declined by 14.77% to $222.4 million in 2024, then spiked by 216.00% to $607.2 million in 2025.
- Its last three reported values are $607.2 million in Q3 2025, $276.4 million for Q2 2025, and $237.3 million during Q1 2025.